Lista de obras -

Antiviral activity of Arthrospira-derived spirulan-like substances

artículo científico publicado en 2006

Appearance of NS3 Q80K mutation in HCV genotype 1a mono- or HIV/HCV co-infected patients in a Berlin laboratory

artículo científico publicado en 2014

Association between HIV-1 coreceptor usage and resistance to broadly neutralizing antibodies

artículo científico publicado en 2014

Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants

artículo científico publicado en 2008

Computational methods for the design of effective therapies against drug resistant HIV strains

artículo científico publicado en 2005

Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.

artículo científico publicado en 2005

Determination of HIV-1 coreceptor tropism in clinical practise.

artículo científico publicado en 2007

Determination of Phenotypic Resistance Cutoffs From Routine Clinical Data

artículo científico publicado en 2016

Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitors

artículo científico publicado en 2016

Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples

artículo científico publicado en 2003

Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype

artículo científico publicado en 2002

Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease

artículo científico publicado en 2007

European recommendations for the clinical use of HIV drug resistance testing: 2011 update

artículo científico publicado el 1 de abril de 2011

Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes

artículo científico publicado en 2003

Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents

artículo científico publicado en 2016

Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy

artículo científico publicado en 2002

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia

artículo científico publicado en 2017

HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge

artículo científico publicado en 2012

Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences

artículo científico publicado en 2014

Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition

artículo científico publicado en 2011

Methods for optimizing antiviral combination therapies

artículo científico publicado en 2003

New dolutegravir resistance pattern identified in a patient failing antiretroviral therapy

artículo científico publicado en 2014

No evidence for persistence of multidrug-resistant viral strains after a 7-month treatment interruption in an HIV-1-infected individual

artículo científico publicado en 2002

Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors

scientific article published on 19 May 2020

Only slight impact of predicted replicative capacity for therapy response prediction

artículo científico publicado en 2010

Persistence of lamivudine-sensitive HIV-1 quasispecies in the presence of lamivudine in vitro and in vivo.

artículo científico publicado en 2007

Prediction of abacavir resistance from genotypic data: impact of zidovudine and lamivudine resistance in vitro and in vivo

artículo científico publicado en 2002

Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients

artículo científico publicado en 2010

Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results

artículo científico publicado en 2003

Results of the first international HIV-1 coreceptor proficiency panel test

artículo científico publicado en 2017

Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment

artículo científico publicado en 2014

Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures

artículo científico publicado en 2006

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation

artículo científico

Technologies for measuring HIV-1 drug resistance

artículo científico publicado en 2002

Tenofovir resistance and resensitization

artículo científico publicado en 2003

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

artículo científico publicado en 2011

The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypes ⬇️

artículo científico publicado el 8 de abril de 2011

The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro

artículo científico publicado en 2010

Lista de obras de

Antiviral activity of Arthrospira-derived spirulan-like substances

Appearance of NS3 Q80K mutation in HCV genotype 1a mono- or HIV/HCV co-infected patients in a Berlin laboratory

Association between HIV-1 coreceptor usage and resistance to broadly neutralizing antibodies

Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants

Computational methods for the design of effective therapies against drug resistant HIV strains

Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.

Determination of HIV-1 coreceptor tropism in clinical practise.

Determination of Phenotypic Resistance Cutoffs From Routine Clinical Data

Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitors

Distinct cross-resistance profiles of the new protease inhibitors amprenavir, lopinavir, and atazanavir in a panel of clinical samples

Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype

Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease

European recommendations for the clinical use of HIV drug resistance testing: 2011 update

Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes

Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents

Genotypic drug resistance interpretation systems--the cutting edge of antiretroviral therapy

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia

HIV-GRADE: a publicly available, rules-based drug resistance interpretation algorithm integrating bioinformatic knowledge

Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences

Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition

Methods for optimizing antiviral combination therapies

New dolutegravir resistance pattern identified in a patient failing antiretroviral therapy

No evidence for persistence of multidrug-resistant viral strains after a 7-month treatment interruption in an HIV-1-infected individual

Non-active site mutants of HIV-1 protease influence resistance and sensitisation towards protease inhibitors

Only slight impact of predicted replicative capacity for therapy response prediction

Persistence of lamivudine-sensitive HIV-1 quasispecies in the presence of lamivudine in vitro and in vivo.

Prediction of abacavir resistance from genotypic data: impact of zidovudine and lamivudine resistance in vitro and in vivo

Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients

Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results

Results of the first international HIV-1 coreceptor proficiency panel test

Safety analysis of raltegravir/truvada regimen in HIV/HCV co-infected patients without switchback after HCV treatment

Superiority of infectivity-based over particle-based methods for quantitation of drug resistant HIV-1 as inocula for cell cultures

Targets for inhibition of HIV replication: entry, enzyme action, release and maturation

Technologies for measuring HIV-1 drug resistance

Tenofovir resistance and resensitization

The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?

The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypes ⬇️

The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro